Genprex, Inc. Uncategorized Contracts & Agreements
19 Contracts & Agreements
- Genprex, Inc. Form of Inducement Grant (Filed With SEC on April 1, 2024)
- Description of Registrant (Filed With SEC on April 1, 2024)
- At The Market Offering Agreement, dated December 13, 2023, by and between Genprex, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on December 13, 2023)
- Description of Registrant's Securities (Filed With SEC on March 31, 2023)
- Form of Indemnity Agreement by and between the Company and its directors and officers, dated as of May 17, 2022 (Filed With SEC on August 12, 2022)
- Description of Registrant's Securities (Filed With SEC on March 30, 2022)
- Option Award Agreement between Genprex, Inc. and Hemant Kumar, PhD dated September 27, 2021 (Filed With SEC on September 28, 2021)
- Offer Letter between Genprex, Inc. and Hemant Kumar, PhD (Filed With SEC on September 28, 2021)
- Option Award Agreement between Genprex, Inc. and Mark S. Berger, M.D. dated September 27, 2021 (Filed With SEC on September 28, 2021)
- Offer Letter between Genprex, Inc. and Mark S. Berger, M.D (Filed With SEC on September 28, 2021)
- Description of Registrant's Securities (Filed With SEC on March 26, 2021)
- Description of Registrant's Securities (Filed With SEC on March 30, 2020)
- Amendment No. 1 to Clinical Study Agreement dated June 25, 2015 (Filed With SEC on September 15, 2017)
- Clinical Study Agreement dated February 10, 2014, by and between The University of Texas M.D. Anderson Cancer Center and the Registrant (Filed With SEC on September 15, 2017)
- Form of Indemnity Agreement by and between the Registrant and its directors and officers (Filed With SEC on September 8, 2017)
- TECHNOLOGY SUBLICENSE AGREEMENT (Filed With SEC on August 18, 2017)
- AGREEMENT Between CONVERGEN LIFESCIENCES, INC. And THE UNIVERSITY OFTEXAS M. D. ANDERSON CANCER CENTER (Filed With SEC on August 18, 2017)
- TECHNOLOGY SUBLICENSE AGREEMENT (Filed With SEC on August 18, 2017)
- CONVERGEN LIFESCIENCES, INC. INVESTMENT UNIT (Filed With SEC on August 18, 2017)